Inhibition of Hepatobiliary Transport Activity by the Antibacterial Agent Fusidic Acid: Insights into Factors Contributing to Conjugated Hyperbilirubinemia/Cholestasis.

Lapham, Kimberly; Novak, Jonathan; Marroquin, Lisa D; Swiss, Rachel; Qin, Shuzhen; Strock, Christopher J; Scialis, Renato; Aleo, Michael D; Schroeter, Thomas; Eng, Heather; Rodrigues, A David; Kalgutkar, Amit S

Lapham, Kimberly; Novak, Jonathan; Marroquin, Lisa D; Swiss, Rachel; Qin, Shuzhen; Strock, Christopher J; Scialis, Renato; Aleo, Michael D; Schroeter, Thomas; Eng, Heather; Rodrigues, A David; Kalgutkar, Amit S.

Afiliação

Qin S; Biological Screening and Assay Development, Cyprotex , Watertown, Massachusetts 02472, United States.
Strock CJ; Biological Screening and Assay Development, Cyprotex , Watertown, Massachusetts 02472, United States.
Kalgutkar AS; Pharmacokinetics, Dynamics, and Metabolism Department, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.

Chem Res Toxicol ; 29(10): 1778-1788, 2016 Oct 17.

Article em En | MEDLINE | ID: mdl-27676153

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article